Press release
Levobupivacaine Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028
The global levobupivacaine market is anticipated to grow at a CAGR of 3.9% during the forecast period (2022-2028). The demand for levobupivacaine is expected to rise due to an increase in the number of plastic surgeries and other cosmetic operations. The rising use of dental implants and sedation dentistry, as well as the growing global senior population, are some of the factors that will drive market expansion in the approaching years. In addition, the number of surgeries and treatments requiring local anesthetics, such as orthopedic surgery, is on the rise which is anticipated to contribute to industry growth.A full report of Levobupivacaine Market is available at:https://orionmarketreports.com/levobupivacaine-market/96822/
The S-enantiomer of the bupivacaine medication, levobupivacaine, is classed as a local anaesthetic. It is a member of the amino amide family and has become quite popular among anesthesiologists as a local anesthetic medication due to its low cardiotoxicity and motor blockage. It is a long-acting anesthetic that was developed in response to a large increase in the reported incidences of cardiac arrest and seizures related to intravascular bupivacaine injection. In comparison to other anesthetic drugs such as ropivacaine and bupivacaine, it has superior pharmacokinetic qualities such as volume of distribution and rate of clearance, making it safe and effective.
In the clinical application segment for levobupivacaine, epidural anesthesia has the biggest market share. It is the most common type of anesthetic used to alleviate pain during delivery. Peripheral nerve blocks are used to numb the nerves of the body part undergoing surgical procedures, and the anesthetic effect lasts beyond the treatment to provide comfort to the patient. Due to the large increase in traumatic accidents needing prompt surgical treatments to address catastrophic injuries, the market is expected to grow rapidly throughout the projected period.
Some major players in the market includeAbbVie Inc., AstraZeneca PLC, Pfizer Inc., Purdue Pharma L.P., Recipharm AB, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.
Company's Product
Recipharm AB offers levobupivacaine hydrochloride, the sodium channel blocker levobupivacaine hydrochloride is used as a long-acting local anaesthetic for epidural anesthesia. Levobupivacaine is the (S)-isomer of bupivacaine, and it has the same efficacy as bupivacaine but with a lower risk of cardiotoxicity. The action potential and sodium transit in neuronal membranes are blocked by levobupivacaine.
Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Clinical Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- AbbVie Inc., AstraZeneca PLC, Pfizer Inc., Purdue Pharma L.P., Recipharm AB,among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Levobupivacaine Market Report by Segment
By Clinical Application
Epidural Anesthesia
Spinal Anesthesia
Peripheral Nerve Blocks
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Levobupivacaine Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028 here
News-ID: 2598573 • Views: …
More Releases from Orion Market Reports
Module Power Supply Market to see Huge Growth by 2031
The Module Power Supply Market is experiencing substantial growth, fueled by increasing demand for efficient, compact, and reliable power solutions across a wide range of industries. These power supplies, which convert electrical power to a suitable form for specific applications, are essential in sectors like telecommunications, automotive, medical devices, and consumer electronics. With technological advancements and rising energy efficiency needs, the market is expected to continue expanding, driven by innovations…
Plasma Spray Guns Market to see Rapid Growth by 2031
The Plasma Spray Guns Market is witnessing significant growth, driven by the rising demand for surface coating and thermal spray applications across industries such as aerospace, automotive, manufacturing, and electronics. Plasma spray guns are widely used for depositing coatings on substrates to enhance their properties, including wear resistance, corrosion resistance, and thermal protection. As industries continue to focus on improving product performance and durability, the plasma spray gun market is…
Plasma Surface Treatment Machine Market Will Generate Record Revenue by 2031
The Plasma Surface Treatment Machine Market is witnessing significant growth as industries increasingly adopt plasma surface treatment technology for enhancing the properties of materials. Plasma surface treatment machines are used to modify the surface characteristics of materials like metals, plastics, and ceramics, offering improvements in adhesion, corrosion resistance, and wear resistance. As the demand for advanced surface treatments rises across automotive, electronics, packaging, and manufacturing sectors, the market for plasma…
Plasma Torch Market Value Projected to Expand by 2031
The Plasma Torch Market is experiencing rapid growth, driven by the increasing demand for high-precision cutting and welding technologies in industries such as manufacturing, automotive, aerospace, and construction. Plasma torches are essential tools in thermal cutting applications, offering fast and accurate cuts on various materials, including metals, plastics, and composites. With advancements in plasma cutting technology and the growing need for energy-efficient solutions, the market for plasma torches continues to…
More Releases for Levobupivacaine
Levobupivacaine Hydrochloride Injection Market Size, Share and Forecast By Key P …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Levobupivacaine Hydrochloride Injection market is anticipated to grow at a compound annual growth rate (CAGR) of 15.68% between 2024 and 2031. The market is expected to grow to USD 26.07 Billion by 2024. The valuation is expected to reach USD 72.26 Billion by 2031.
The market for levobupivacaine hydrochloride injection is expanding rapidly due to the growing number of surgical procedures and…
Levobupivacaine Hydrochloride Market Set to Expand at a Staggering 7.4% CAGR, Re …
Levobupivacaine hydrochloride, a long-acting local anesthetic, has been gaining significant traction in the medical field owing to its effectiveness and lower cardiotoxicity compared to its racemic counterpart, bupivacaine. This compound is primarily utilized in regional anesthesia for surgeries ranging from orthopedic procedures to obstetrics, showcasing a broad spectrum of applications. As the demand for safer and efficient anesthesia continues to rise, the Levobupivacaine Hydrochloride market is poised for steady growth…
Levobupivacaine Market to Witness Robust Expansion by 2029
Levobupivacaine Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 17.69% from 2024 to 2030. Levobupivacaine has emerged as a cornerstone, revolutionizing patient care and surgical procedures. As the medical landscape evolves, the Levobupivacaine market stands poised for significant growth and innovation, driven by its efficacy, safety profile, and expanding applications across various medical disciplines.
In order to…
Levobupivacaine Hydrochloride Market 2023 | Detailed Report
The Levobupivacaine Hydrochloride research report studies primary and secondary research in order to analyze the data effectively. The market study further also draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant market key players are also enlisted in order to deliver readers with in-depth analysis about industry strategies.
The Levobupivacaine…
Global Levobupivacaine Market Regional Outlook 2021|Cellix Bio, UCB, AbbVie
Complete study of the global Levobupivacaine market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Levobupivacaine industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided accurate…
Growth Opportunities in the Levobupivacaine Market and Leading Key Vendors (Cell …
The exclusive research report on Global Levobupivacaine market 2020 categorizes the market based on market overview, regions, analysis by types and applications, market dynamics, manufacturers profiles and forecast 2020-2024.
Overview of Global Levobupivacaine Market:
Levobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted pipecoloxylidide. It is the S-enantiomer of bupivacaine. Levobupivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Chirocaine.
The report contains a complete product overview…
